Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

  Malignant Melanoma

  Free Subscription


30.12.2018

1 Biochem Biophys Res Commun
3 Br J Dermatol
1 Int J Cancer
4 J Am Acad Dermatol
1 J Invest Dermatol
2 J Surg Oncol
1 Melanoma Res
1 PLoS One


  Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    Biochem Biophys Res Commun

  1. NAKAMURA Y, Nakahata S, Kondo Y, Izumi A, et al
    Overexpression of absent in melanoma 2 in oral squamous cell carcinoma contributes to tumor progression.
    Biochem Biophys Res Commun. 2018 Dec 23. pii: S0006-291X(18)32709.
    PubMed     Text format     Abstract available


    Br J Dermatol

  2. MIURA K, Olsen CM, Rea S, Marsden J, et al
    Do airline pilots and cabin crew have raised risks of melanoma and other skin cancers? Systematic review and meta-analysis.
    Br J Dermatol. 2018 Dec 26. doi: 10.1111/bjd.17586.
    PubMed     Text format     Abstract available

  3. FENTON GL, Smit AK, Keogh L, Cust AE, et al
    Exploring the Emotional and Behavioural Reactions to Receiving Personalised Melanoma Genomic Risk Information: A Qualitative Study.
    Br J Dermatol. 2018 Dec 22. doi: 10.1111/bjd.17582.
    PubMed     Text format     Abstract available

  4. HWANG SJE, Fernandez-Penas P
    Pigmentary evolution with pembrolizumab use.
    Br J Dermatol. 2018;178:32-33.
    PubMed     Text format    


    Int J Cancer

  5. WEIDELE K, Stojanovic N, Feliciello G, Markiewicz A, et al
    Microfluidic enrichment, isolation and characterization of disseminated melanoma cells from lymph node samples.
    Int J Cancer. 2018 Dec 26. doi: 10.1002/ijc.32092.
    PubMed     Text format     Abstract available


    J Am Acad Dermatol

  6. STIEGEL E, Vij A
    Reply to: "Comment on 'Prognostic value of sentinel lymph node biopsy according to Breslow thickness for cutaneous melanoma'".
    J Am Acad Dermatol. 2018;79:e55-e56.
    PubMed     Text format    

  7. BOUSSEMART L, Johnson A, Schrock AB, Pal SK, et al
    Tumor mutational burden and response to PD-1 inhibitors in a case series of patients with metastatic desmoplastic melanoma.
    J Am Acad Dermatol. 2018 Dec 18. pii: S0190-9622(18)33091.
    PubMed     Text format     Abstract available

  8. MARCHETTI MA, Bartlett EK, Dusza SW, Bichakjian CK, et al
    Use of a prognostic gene expression profile test for T1 cutaneous melanoma: will it help or harm patients?
    J Am Acad Dermatol. 2018 Dec 22. pii: S0190-9622(18)33107.
    PubMed     Text format    

  9. GASTMAN BR, Cook RW
    Reply to "Use of a prognostic gene expression profile test for T1 cutaneous melanoma: will it help or harm patients?"
    J Am Acad Dermatol. 2018 Dec 23. pii: S0190-9622(18)33105.
    PubMed     Text format    


    J Invest Dermatol

  10. OLSEN CM, Green AC, Pandeya N, Whiteman DC, et al
    Trends in melanoma incidence rates in eight susceptible populations to 2015.
    J Invest Dermatol. 2018 Dec 19. pii: S0022-202X(18)30008.
    PubMed     Text format    


    J Surg Oncol

  11. LIU JY, Lowe M
    Neoadjuvant Treatments for Advanced Resectable Melanoma.
    J Surg Oncol. 2018 Dec 27. doi: 10.1002/jso.25352.
    PubMed     Text format     Abstract available

  12. CROMPTON JG, Gilbert E, Brady MS
    Clinical implications of the eighth edition of the American Joint Committee on Cancer melanoma staging.
    J Surg Oncol. 2018 Dec 21. doi: 10.1002/jso.25343.
    PubMed     Text format     Abstract available


    Melanoma Res

  13. LEE WJ, Lee MH, Kim HT, Won CH, et al
    Prognostic significance of CD163 expression and its correlation with cyclooxygenase-2 and vascular endothelial growth factor expression in cutaneous melanoma.
    Melanoma Res. 2018 Dec 19. doi: 10.1097/CMR.0000000000000549.
    PubMed     Text format     Abstract available


    PLoS One

  14. WADA H, Shimizu A, Osada T, Tanaka Y, et al
    Development of a novel immunoproteasome digestion assay for synthetic long peptide vaccine design.
    PLoS One. 2018;13:e0199249.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Malignant Melanoma is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: